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Introduction: Recent finding suggest that inflammation plays a role in athero-
sclerosis and its acute complications. Several known mechanisms may play at least
a partial role in this process. One of the most likely mechanisms involves
lipopolysaccharide (LPS) and its receptor, CD14. The C(-260)T single nucleotide
polymorphism in the promoter region of the CD14 receptor gene has been reported
to be associated with a higher risk of MI. Others studies, however, have not cor-
roborated these findings. Considering the contradictory results, the aim of the
present study was to investigate the possible association between the CD14 C(-
260)T polymorphism and the risk of MI in the Tunisian population.
Material and Methods: A total of 333 Tunisian patients with MI and 345 healthy
controls were included in the study. Genotyping was performed by polymerase
chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
Results: The frequency of TT homozygous genotype for the CD14 C(-
260)T polymorphism was 24.9% in MI patients and 24.0% in the control
group. However, the genotype distribution and allele frequencies were not sig-
nificantly different between MI and controls subjects. Moreover, the odds ratio
for MI associated with the T allele failed to reach statistical significance
(OR=1.08; 95% CI: 0.86 - 1.34; P=NS).
Conclusion: These results do not support the hypothesis that the C-260T poly-
morphism of CD14 gene contributes to the genetic susceptibility to MI in the
Tunisian population studied.
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Introduction: Arginase I (ARG I) is the final enzyme of the urea cycle that
converts L-arginine to urea and ornithine. Emerging evidence have identified
ARG I as a critical regulator for nitric oxide (NO) production via nitric oxide
synthase (NOS).
Therefore upregulation of ARG I inhibit NOS-mediated NO and may con-
tribute to endothelial dysfunction. In addition, pathophysiological role of ARG
I on vascular disease have been extensively documented, and some recent
studies support a role for ARG I in the development and complications of cor-
onary artery disease (CAD). The aim of the present study is to investigate the
possible association between rs 2781666 G/T polymorphism of ARG I gene
and myocardial infarction (MI) in the Tunisian population.
Methods: In a case-control study, a total of 321 patients with MI and
436 controls were included. The rs 2781666 G/T polymorphism of ARG I was
determined by PCR-RFLP analysis.
Results: Patients with MI had significantly higher frequency of TT genotype com-
pared to controls (10.3 % vs 6.7 %; OR (95 % CI), 2.05 (1.19 - 3.52), p=0.009).
The MI patients showed higher frequency of T allele compared to the controls
(0.32 vs 0.23, OR (95 % CI), 1.58(1.25 - 2.00), p<0.001). The association between
rs 2781666 G/T polymorphism of ARG I gene and MI was no longer significant
after adjustment for other well established risk factors. 
Conclusion: Our results revealed a significant but not independent associ-
ation between rs2781666 G/T polymorphism of ARG I gene and (MI) in the
Tunisian population.
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Objective: Resistin is a polypeptide (hormone) that is specifically secreted
from adipocytes. It plays an important role in communication between adi-
posity and insulin resistance and it has been linked to the pathogenesis of ath-
erosclerosis. Recently, -420C>G, a variant located in the promoter region of
the resistin gene (RETN) (rs1862513) was identified. The aim of this study
was to investigate the association between this polymorphism and the risk of
myocardial infarction (MI) in the Tunisian population.
Design and methods: A total of 787 unrelated male Tunisian subjects
including 455 healthy controls and 332 patients who had survived a first MI
were prospectively recruited. Standard definitions and criteria for MI diagnosis
were employed. Blood samples were obtained after an overnight fast. Serum
glucose, TC and TG were measured by standardized enzymatic methods using
commercial kits (Roche Diagnostics, Mannheim, Germany) on a Hitachi
912 analyzer. Genomic DNA was extracted from peripheral blood leukocytes
according to standard methods. -420C>G polymorphism genotypes were deter-
mined by polymerase chain reaction followed by restriction analysis with
5 units of BbsI. Digested products were separated on 2.5% agarose gel with
ethidium bromide staining.
Results: The frequencies of RETN -420G allele in MI group, and control
group were 0.45 and 0.41, which are met with the Hardy-Weinberg equilibrium.
Compared with controls, there was no significant differences in distribution of
genotypes and allele frequencies of -420 C>G polymorphic site in MI patients and
controls. In addition, there was no significant difference between the genotypes
with lipid profiles. 
Conclusion: Our data suggest that the RETN -420C>G polymorphism is
not associated with an increased risk of MI in a Tunisian population.  
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Aspirin sensitive Aspirin resistant p
Platelet volume (fl) 8.78±0.26 8.82±0.30 0.92
Reticulated platelet (%) 8.4±0.52 8.6±0.76 0.82
Serup P selectin (ng/ml) 42.6±4.29 42.9±4.75 0.97
Platelet P selectin (%) 11.1±1.0 9.5±1.5 0.35
Serum thrombopoietin (pg/ml) 130.6±11.3 319.9±97.8 0.01
